- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 471/14
Total number of patents in this class: 2348
10-year publication summary
|
107
|
145
|
160
|
162
|
172
|
206
|
191
|
236
|
211
|
110
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5735 |
67 |
| Incyte Corporation | 1066 |
61 |
| Intra-Cellular Therapies, Inc. | 437 |
59 |
| Shionogi & Co., Ltd. | 883 |
38 |
| Bristol-myers Squibb Company | 4757 |
37 |
| Novartis AG | 10173 |
31 |
| Gilead Sciences, Inc. | 2236 |
29 |
| King Faisal University | 934 |
28 |
| Genentech, Inc. | 4114 |
27 |
| Merck Sharp & Dohme LLC | 3737 |
26 |
| Janssen Pharmaceutica N.V. | 3160 |
23 |
| Sudo Biosciences Limited | 32 |
22 |
| Vertex Pharmaceuticals Incorporated | 1579 |
18 |
| F. Hoffmann-La Roche AG | 7808 |
17 |
| Janssen Sciences Ireland Unlimited Company | 375 |
16 |
| Dana-Farber Cancer Institute, Inc. | 2666 |
15 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 876 |
15 |
| Samsung Display Co., Ltd. | 38817 |
14 |
| Pfizer Inc. | 3409 |
14 |
| Amgen Inc. | 4440 |
14 |
| Other owners | 1777 |